CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer

Overview of attention for article published in BMC Cancer, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 2 news outlets

twitter: 4 X users

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 56 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Selective CDK2 Inhibitor Undergoes Investigation in CCNE1-High Tumors

OncLive, 17 Apr 2023

Breast Cancer Preclinical data have demonstrated activity of a novel, small molecule CDK2 inhibitor INCB123667 in CDK2/cyclin…

BMC Cancer | Translational oncology

Medical Health News, 28 Feb 2019

BMC Cancer Translational oncology This section aims to consider publications which bridge laboratory basic science and applied…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.